Clearside Biomedical Total Liabilities

Clearside Biomedical (CLSD) currently reports a total liabilities of $66M as of September 2025. That compares with $64M in the prior-year period — up 2.6% year over year. Use the charts on this page to explore Clearside Biomedical's total liabilities history and peer comparisons.

Clearside Biomedical's total liabilities increased from $64M to $66M — a 2.6% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clearside Biomedical reported $66M in total liabilities as of September 2025. That compares with $64M in the prior-year period — up 2.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $66M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clearside Biomedical, and consider following CLSD for alerts when major investors trade the stock.

Clearside Biomedical is classified in the Healthcare sector. On total liabilities, it currently shows $66M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLSD with unrelated industries.